Hiscox is set to exit digital insurance processing platform Indio Technologies in an acquisition by Applied Systems that follows $28m in venture funding.
Month: December 2019
Jasper springs to life with $35m
Alexandria Venture Investments has backed a series A round for Jasper Therapeutics, which is developing a conditioning agent for patients awaiting stem cell transplants.
Akoya accepts Agilent investment to raise $50m
Agilent Technologies contributed to a $50m round for the tissue-imaging technology developer, which has earmarked the funds for product development.
SoftBank buys into Style Theory’s $15m series B
Fashion hire service Style Theory collected the cash from existing investor SoftBank Ventures Asia, Paradise Group and Alpha JWC Ventures.
Sweetome gets two new inhabitants
Sweetome has acquired corporate-backed short-term accommodation platforms City Home and iYoujia, with Tencent, Alibaba, Tujia and Trip.com scoring exits.
Vision Fund II heads for reduced size
SoftBank’s second Vision Fund could close 30% lower than its $98.6bn first fund as potential LPs continue negotiations with the corporate.
Chime checks in to $500m series E
Mobile bank operator Chime has closed a $500m series E round at a $5.8bn valuation – an increase of $4.3bn in nine months – backed by Access Industries.
Vroom gains momentum with $254m series H
AutoNation-backed Vroom has now raised $721m in funding altogether after closing a $254m series H round led by Durable Capital Partners.
Group 42 oils HeyGears with $60m
The 3D printing technology provider received $60m from Group 42 in the form of a series B1 investment that marks the corporate’s third in a Chinese company this year.
Plexo flexes corporate connections to close first fund
Plexo Capital, a venture capital spinoff from Alphabet subsidiary GV, has raised $42.5m from LPs that include Alphabet, Intel Capital and Cisco Investments.
Anaconda consumes $22m
Existing backer Banco Sabadell Venture Capital contributed to a round that will help the stroke surgery device developer fund clinical studies.
Ribo rips into series C1 round
Legend Capital returned as the RNA drug developer secured $28.8m in a round co-led by Panlin Capital and Trinity Innovation Fund.
Hummingbird feeds on $19m
Kooksoondang Brewery took part in a series B round for oncology antibody developer Hummingbird Bioscience as it prepares to move its lead assets into the clinic.
Nutriati heats up with series C funding
PLT Health Solutions and existing backer Tate & Lyle Ventures contributed to a $12.7m round for vegan ingredients supplier Nutriati to take its total funding to more than $22m.